NCT07637071Not yet recruiting
Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia
A Multi-center, Randomized, Double-Blind, Placebo- Controlled Pilot Study to Evaluate the Efficacy and Safety of Xtressé™ Gummy-Based Nutraceutical Supplement in Men With Androgenic Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Restore Biologics Holdings, Inc. dba Xtressé
- Participants (registry)
- 48
- Start
- September 2026 (planned)
- Primary completion
- April 2027 (planned)
- Study completion
- June 2027 (planned)
- Last registry update
- August 2026
- Countries
- United States
Conditions studied: Androgenic Alopecia, Hair Loss/Baldness, Hair Thinning
Interventions: Xtressé Hair Growth Gummies, Placebo Comparator
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.